10 Best Short Squeeze Stocks to Buy According to Analysts
Stock market trading has an ever-changing environment. Short squeeze is among the few phenomena capable of capturing and holding the attention of such markets.
Arrivent Biopharma Inc. (AVBP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hillhouse Capital Management Lei Zhang | 4,484,672 | $97,631,309 | 3.14% | |
| 2. | Suvretta Capital Management Aaron Cowen | 3,412,788 | $74,296,395 | +47% | 2.24% |
| 3. | OrbiMed Advisors Samuel Isaly | 3,027,328 | $65,904,931 | 1.65% | |
| 4. | Octagon Capital Advisors Ting Jia | 1,946,054 | $42,365,596 | -6% | 9.3% |
| 5. | Siren L.L.C. Raymond Debbane | 700,000 | $15,239,000 | 0.79% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 555,555 | $9,999,990.00 | 4,484,672 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 59,454 | $1,096,926 | 0.21% | |
| 2. | 3,100 | $57,195 | 0% | |
| 3. | 368 | $6,790 | 0% | |
| 4. | 313 | $5,775 | 0% | |
| 5. | 190 | $3,506 | 0% |
News See All
